Global Influenza Diagnostics Market Size, Demand, Forecast to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Influenza Diagnostics Market Size Analysis

Global Influenza Diagnostics Market Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Traditional Diagnostic Test
  1. By Value
  2. RIDT
    1. RIDT By Value
  3. Cell Culture
    1. Cell Culture By Value
  4. DFA
    1. DFA By Value
  5. Serological Assays
    1. Serological Assays By Value
3. Molecular Diagnostic Test
  1. By Value
  2. RT-PCR
    1. RT-PCR By Value
  3. INNAT
    1. INNAT By Value
    2. TMA
      1. TMA By Value
    3. LAMP
      1. LAMP By Value
    4. NASBA
      1. NASBA By Value
    5. Other INNAT
      1. Other INNAT By Value
  4. Other Molecular Tests
    1. Other Molecular Tests By Value
By Influenza Type
1. Introduction
  1. Influenza Type By Value
2. Influenza A
  1. By Value
3. Influenza B
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospital
  1. By Value
3. Point-of-Care Testing
  1. By Value
4. Diagnostic Centers
  1. By Value
5. Others
  1. By Value

North America Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Traditional Diagnostic Test
  1. By Value
  2. RIDT
    1. RIDT By Value
  3. Cell Culture
    1. Cell Culture By Value
  4. DFA
    1. DFA By Value
  5. Serological Assays
    1. Serological Assays By Value
3. Molecular Diagnostic Test
  1. By Value
  2. RT-PCR
    1. RT-PCR By Value
  3. INNAT
    1. INNAT By Value
    2. TMA
      1. TMA By Value
    3. LAMP
      1. LAMP By Value
    4. NASBA
      1. NASBA By Value
    5. Other INNAT
      1. Other INNAT By Value
  4. Other Molecular Tests
    1. Other Molecular Tests By Value
By Influenza Type
1. Introduction
  1. Influenza Type By Value
2. Influenza A
  1. By Value
3. Influenza B
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospital
  1. By Value
3. Point-of-Care Testing
  1. By Value
4. Diagnostic Centers
  1. By Value
5. Others
  1. By Value
U.S.
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Traditional Diagnostic Test
    1. By Value
    2. RIDT
      1. RIDT By Value
    3. Cell Culture
      1. Cell Culture By Value
    4. DFA
      1. DFA By Value
    5. Serological Assays
      1. Serological Assays By Value
  3. Molecular Diagnostic Test
    1. By Value
    2. RT-PCR
      1. RT-PCR By Value
    3. INNAT
      1. INNAT By Value
      2. TMA
        
        TMA By Value
      3. LAMP
        
        LAMP By Value
      4. NASBA
        
        NASBA By Value
      5. Other INNAT
        
        Other INNAT By Value
    4. Other Molecular Tests
      1. Other Molecular Tests By Value
2. By Influenza Type
  1. Introduction
    1. Influenza Type By Value
  2. Influenza A
    1. By Value
  3. Influenza B
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospital
    1. By Value
  3. Point-of-Care Testing
    1. By Value
  4. Diagnostic Centers
    1. By Value
  5. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Traditional Diagnostic Test
  1. By Value
  2. RIDT
    1. RIDT By Value
  3. Cell Culture
    1. Cell Culture By Value
  4. DFA
    1. DFA By Value
  5. Serological Assays
    1. Serological Assays By Value
3. Molecular Diagnostic Test
  1. By Value
  2. RT-PCR
    1. RT-PCR By Value
  3. INNAT
    1. INNAT By Value
    2. TMA
      1. TMA By Value
    3. LAMP
      1. LAMP By Value
    4. NASBA
      1. NASBA By Value
    5. Other INNAT
      1. Other INNAT By Value
  4. Other Molecular Tests
    1. Other Molecular Tests By Value
By Influenza Type
1. Introduction
  1. Influenza Type By Value
2. Influenza A
  1. By Value
3. Influenza B
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospital
  1. By Value
3. Point-of-Care Testing
  1. By Value
4. Diagnostic Centers
  1. By Value
5. Others
  1. By Value
U.K.
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Traditional Diagnostic Test
    1. By Value
    2. RIDT
      1. RIDT By Value
    3. Cell Culture
      1. Cell Culture By Value
    4. DFA
      1. DFA By Value
    5. Serological Assays
      1. Serological Assays By Value
  3. Molecular Diagnostic Test
    1. By Value
    2. RT-PCR
      1. RT-PCR By Value
    3. INNAT
      1. INNAT By Value
      2. TMA
        
        TMA By Value
      3. LAMP
        
        LAMP By Value
      4. NASBA
        
        NASBA By Value
      5. Other INNAT
        
        Other INNAT By Value
    4. Other Molecular Tests
      1. Other Molecular Tests By Value
2. By Influenza Type
  1. Introduction
    1. Influenza Type By Value
  2. Influenza A
    1. By Value
  3. Influenza B
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospital
    1. By Value
  3. Point-of-Care Testing
    1. By Value
  4. Diagnostic Centers
    1. By Value
  5. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Traditional Diagnostic Test
  1. By Value
  2. RIDT
    1. RIDT By Value
  3. Cell Culture
    1. Cell Culture By Value
  4. DFA
    1. DFA By Value
  5. Serological Assays
    1. Serological Assays By Value
3. Molecular Diagnostic Test
  1. By Value
  2. RT-PCR
    1. RT-PCR By Value
  3. INNAT
    1. INNAT By Value
    2. TMA
      1. TMA By Value
    3. LAMP
      1. LAMP By Value
    4. NASBA
      1. NASBA By Value
    5. Other INNAT
      1. Other INNAT By Value
  4. Other Molecular Tests
    1. Other Molecular Tests By Value
By Influenza Type
1. Introduction
  1. Influenza Type By Value
2. Influenza A
  1. By Value
3. Influenza B
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospital
  1. By Value
3. Point-of-Care Testing
  1. By Value
4. Diagnostic Centers
  1. By Value
5. Others
  1. By Value
China
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Traditional Diagnostic Test
    1. By Value
    2. RIDT
      1. RIDT By Value
    3. Cell Culture
      1. Cell Culture By Value
    4. DFA
      1. DFA By Value
    5. Serological Assays
      1. Serological Assays By Value
  3. Molecular Diagnostic Test
    1. By Value
    2. RT-PCR
      1. RT-PCR By Value
    3. INNAT
      1. INNAT By Value
      2. TMA
        
        TMA By Value
      3. LAMP
        
        LAMP By Value
      4. NASBA
        
        NASBA By Value
      5. Other INNAT
        
        Other INNAT By Value
    4. Other Molecular Tests
      1. Other Molecular Tests By Value
2. By Influenza Type
  1. Introduction
    1. Influenza Type By Value
  2. Influenza A
    1. By Value
  3. Influenza B
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospital
    1. By Value
  3. Point-of-Care Testing
    1. By Value
  4. Diagnostic Centers
    1. By Value
  5. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Traditional Diagnostic Test
  1. By Value
  2. RIDT
    1. RIDT By Value
  3. Cell Culture
    1. Cell Culture By Value
  4. DFA
    1. DFA By Value
  5. Serological Assays
    1. Serological Assays By Value
3. Molecular Diagnostic Test
  1. By Value
  2. RT-PCR
    1. RT-PCR By Value
  3. INNAT
    1. INNAT By Value
    2. TMA
      1. TMA By Value
    3. LAMP
      1. LAMP By Value
    4. NASBA
      1. NASBA By Value
    5. Other INNAT
      1. Other INNAT By Value
  4. Other Molecular Tests
    1. Other Molecular Tests By Value
By Influenza Type
1. Introduction
  1. Influenza Type By Value
2. Influenza A
  1. By Value
3. Influenza B
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospital
  1. By Value
3. Point-of-Care Testing
  1. By Value
4. Diagnostic Centers
  1. By Value
5. Others
  1. By Value
UAE
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Traditional Diagnostic Test
    1. By Value
    2. RIDT
      1. RIDT By Value
    3. Cell Culture
      1. Cell Culture By Value
    4. DFA
      1. DFA By Value
    5. Serological Assays
      1. Serological Assays By Value
  3. Molecular Diagnostic Test
    1. By Value
    2. RT-PCR
      1. RT-PCR By Value
    3. INNAT
      1. INNAT By Value
      2. TMA
        
        TMA By Value
      3. LAMP
        
        LAMP By Value
      4. NASBA
        
        NASBA By Value
      5. Other INNAT
        
        Other INNAT By Value
    4. Other Molecular Tests
      1. Other Molecular Tests By Value
2. By Influenza Type
  1. Introduction
    1. Influenza Type By Value
  2. Influenza A
    1. By Value
  3. Influenza B
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospital
    1. By Value
  3. Point-of-Care Testing
    1. By Value
  4. Diagnostic Centers
    1. By Value
  5. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Traditional Diagnostic Test
  1. By Value
  2. RIDT
    1. RIDT By Value
  3. Cell Culture
    1. Cell Culture By Value
  4. DFA
    1. DFA By Value
  5. Serological Assays
    1. Serological Assays By Value
3. Molecular Diagnostic Test
  1. By Value
  2. RT-PCR
    1. RT-PCR By Value
  3. INNAT
    1. INNAT By Value
    2. TMA
      1. TMA By Value
    3. LAMP
      1. LAMP By Value
    4. NASBA
      1. NASBA By Value
    5. Other INNAT
      1. Other INNAT By Value
  4. Other Molecular Tests
    1. Other Molecular Tests By Value
By Influenza Type
1. Introduction
  1. Influenza Type By Value
2. Influenza A
  1. By Value
3. Influenza B
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospital
  1. By Value
3. Point-of-Care Testing
  1. By Value
4. Diagnostic Centers
  1. By Value
5. Others
  1. By Value
Brazil
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Traditional Diagnostic Test
    1. By Value
    2. RIDT
      1. RIDT By Value
    3. Cell Culture
      1. Cell Culture By Value
    4. DFA
      1. DFA By Value
    5. Serological Assays
      1. Serological Assays By Value
  3. Molecular Diagnostic Test
    1. By Value
    2. RT-PCR
      1. RT-PCR By Value
    3. INNAT
      1. INNAT By Value
      2. TMA
        
        TMA By Value
      3. LAMP
        
        LAMP By Value
      4. NASBA
        
        NASBA By Value
      5. Other INNAT
        
        Other INNAT By Value
    4. Other Molecular Tests
      1. Other Molecular Tests By Value
2. By Influenza Type
  1. Introduction
    1. Influenza Type By Value
  2. Influenza A
    1. By Value
  3. Influenza B
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospital
    1. By Value
  3. Point-of-Care Testing
    1. By Value
  4. Diagnostic Centers
    1. By Value
  5. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Influenza Diagnostics Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

F. Hoffmann-La Roche AG
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Hologic, Becton
Dickinson and Company
DiaSorin S.p.A
Luminex Corporation
Meridian Bioscience
GenMark Diagnostics
SA Scientific
Sekisui Diagnostics
bioMérieux SA
Danaher Corporation
Siemens Healthineers
Altona Diagnostics
CorisBioConcept

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment